Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Jung's paternity reveal exposes where Korea stands on extramarital babies

    Jung's paternity reveal exposes where Korea stands on extramarital babies
  2. 2

    Samsung entangled in legal risks amid calls for drastic reform

    Samsung entangled in legal risks amid calls for drastic reform
  3. 3

    Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul

    Heavy snow alerts issued in greater Seoul area, Gangwon Province; over 20 cm of snow seen in Seoul
  4. 4

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'

    [Herald Interview] 'Trump will use tariffs as first line of defense for American manufacturing'
  5. 5

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations

    Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
  1. 6

    [Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle

    [Health and care] Getting cancer young: Why cancer isn’t just an older person’s battle
  2. 7

    Seoul blanketed by heaviest Nov. snow, with more expected

    Seoul blanketed by heaviest Nov. snow, with more expected
  3. 8

    K-pop fandoms wield growing influence over industry decisions

    K-pop fandoms wield growing influence over industry decisions
  4. 9

    [Graphic News] International marriages on rise in Korea

    [Graphic News] International marriages on rise in Korea
  5. 10

    Korea's auto industry braces for Trump’s massive tariffs in Mexico

    Korea's auto industry braces for Trump’s massive tariffs in Mexico
피터빈트

SK Biopharm, Hanmi sign deal to sell epilepsy drug

By Korea Herald

Published : April 22, 2012 - 21:09

    • Link copied

SK Biopharmaceuticals Co. said Sunday it established a strategic partnership with Hanmi Pharm Co. to sell a nasal spray-type epilepsy drug in Korea and China.

Hanmi and its Chinese arm will get the approval for sales and handle marketing in Korea and China, under the partnership.

The diazepam nasal spray quickly transfers the diazepam substance to the brain through the mucous membranes inside the nasal cavity, allowing swift treatment, according to SK Biopharm.

The pharmaceutical company expects to commercialize the drug in Korea next year and in China in 2015.

SK Biopharm plans to file for approval on the new drug sales through its U.S. importer to the U.S. Food and Drug Administration in the first half of this year after completing clinical trials.

(sophie@heraldcorp.com)

More from Headlines